Tolvaptan: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: ==Uses== Tolvaptan can be used for euvolemic or hypervolemic hyponatremia.<ref name="pmid17105757">{{cite journal| author=Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerw...) |
imported>Robert Badgett mNo edit summary |
||
| Line 8: | Line 8: | ||
==References== | ==References== | ||
< | <references/> | ||
Revision as of 10:17, 31 May 2010
Uses
Tolvaptan can be used for euvolemic or hypervolemic hyponatremia.[1][2]
Tolvaptan can be used for heart failure.[3][4]
References
- ↑ Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS et al. (2006). "Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.". N Engl J Med 355 (20): 2099-112. DOI:10.1056/NEJMoa065181. PMID 17105757. Research Blogging.
- ↑ (2009) Tolvaptan (Samsca) for Hyponatremia The Medical Letter
- ↑ Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K et al. (2007). "Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.". JAMA 297 (12): 1332-43. DOI:10.1001/jama.297.12.1332. PMID 17384438. Research Blogging.
- ↑ Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K et al. (2007). "Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.". JAMA 297 (12): 1319-31. DOI:10.1001/jama.297.12.1319. PMID 17384437. Research Blogging.